SPONSOR
Jonsson Comprehensive Cancer Center
Total Trials
6
Recruiting
6
Phases
Phase 2, Phase 4
Conditions studied: Head and Neck CarcinomaLocalized Head and Neck CarcinomaMetastatic Head and Neck CarcinomaRecurrent Head and Neck CarcinomaEarly-stage Breast CancerHormone Receptor Positive Breast CarcinomaInvasive Breast CancerStage II Breast CancerStage IIA Breast CancerStage IIB Breast Cancer
NCT06572423
Recruiting
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)
Head and Neck Carcinoma
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Early-stage Breast Cancer
NCT06288113 Phase 2
Recruiting
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
Castration-Resistant Prostate Carcinoma
NCT02701153
Recruiting
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Recurrent Adult Soft Tissue Sarcoma
NCT06934239 Phase 4
Recruiting
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Breast Cancer Screening
NCT07339085
Recruiting
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
Malignant Brain Neoplasm